PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs
- Authors
- Kim, E.H.; Lee, J.; Kwak, G.; Jang, H.; Kim, H.; Cho, H.; Jang, Y.; Choi, J.; Chi, S.-G.; Kim, K.; Kwon, I.C.; Yang, Y.; Kim, S.H.
- Issue Date
- 5월-2022
- Publisher
- Elsevier B.V.
- Keywords
- anti-miRNA delivery; B16 melanoma; miR-21; PD-L1; Tumor-associated macrophage
- Citation
- Journal of Controlled Release, v.345, pp.62 - 74
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Controlled Release
- Volume
- 345
- Start Page
- 62
- End Page
- 74
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/140178
- DOI
- 10.1016/j.jconrel.2022.02.031
- ISSN
- 0168-3659
- Abstract
- Upregulation of oncogenic miRNA21 (miR-21) plays a pivotal role in proliferation, migration and invasion of cancer cells. In addition to cancer cells, tumor-associated macrophages (TAMs) also have high abundance of miR-21, which accelerates malignant progression of tumors in the late stages of carcinogenesis. Despite of the pro-tumorigenic functions of miR-21 in TAMs and cancer cells, reliable therapeutic strategies to simultaneously inhibit miR-21 activity in both types of cell have not yet been developed. In this study, we designed a dual-targeting drug delivery system of miR-21 inhibitors that could bind to both tumor cells and macrophages with overexpressed PD-L1 receptors. This peptide-oligonucleotide conjugate (Pep-21) consists of a PDL1-binding peptide covalently linked with an anti-miR-21 inhibitor via click chemistry. Pep-21 was preferentially internalized in both cell types, consequently depleting endogenous miR-21. Our studies found that Pep-21 treatment reduced tumor cell migration, reprogrammed immunosuppressive M2-type TAMs into M1-type macrophages, and restrained tumor progression. Collectively, neutralization of miR-21 activity in both cancer cells and TAMs can be a promising strategy for effective antitumor responses. © 2022 Elsevier B.V.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Life Sciences and Biotechnology > Division of Life Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.